Yes - I think long-term it's a buy anywhere around this $1.50 mark, might grab some slightly lower, but the SP has been reluctant to go much lower as buyers keep hopping on. Strong stock
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025